Sign In

Login

Password

Forgot Password ? Sign Up

Benzodiazepiny (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Benzodiazepiny" in Czech language version.

refsWebsite
Global rank Czech rank
76nih.gov
4th place
8th place
51doi.org
2nd place
4th place
15web.archive.org
1st place
1st place
6books.google.com
3rd place
25th place
3archive.org
6th place
10th place
3benzo.org.uk
low place
7,947th place
3aafp.org
1,916th place
1,573rd place
3psychiatrist.com
low place
low place
2webcitation.org
24th place
71st place
2psychiatryonline.org
4,032nd place
4,117th place
1expert-reviews.com
low place
low place
1parliament.uk
367th place
760th place
1psychiatryonline.com
low place
low place
1nelm.nhs.uk
low place
low place
1nice.org.uk
3,258th place
9,541st place
1wiley.com
222nd place
83rd place
1worldcat.org
5th place
3rd place
1movementdisorders.org
low place
low place
1rcpsych.org
low place
low place
1whoindia.org
low place
low place
1medscape.com
719th place
451st place
1bmj.com
1,226th place
800th place
1aappublications.org
3,763rd place
3,157th place

aafp.org

aappublications.org

pediatrics.aappublications.org

  • American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics. 1998, s. 1079–88. Dostupné online. PMID 9614425. 

archive.org

  • Shorter E. A Historical Dictionary of Psychiatry. [s.l.]: Oxford University Press, 2005. Dostupné online. ISBN 0-19-517668-5. Kapitola Benzodiazepines, s. 41–2. 
  • Moody D. Handbook of Drug Interactions: a Clinical and Forensic Guide. Redakce Raymon LP, Mozayani A (eds.). [s.l.]: Humana, 2004. Dostupné online. ISBN 1-58829-211-8. Kapitola Drug interactions with benzodiazepines, s. 3–88. 
  • Roach SS, Ford SM. Introductory Clinical Pharmacology. 8th. vyd. [s.l.]: Lippincott Williams & Wilkins, 2006. Dostupné online. ISBN 978-0-7817-7595-3. Kapitola Sedatives and hypnotics, s. 236. 

benzo.org.uk

bmj.com

  • Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ. 1998, s. 839–43. Dostupné online. PMID 9748174. 

books.google.com

  • D. MAIURO PHD, Roland. Handbook of Integrative Clinical Psychology, Psychiatry, and Behavioral Medicine: Perspectives, Practices, and Research. [s.l.]: Springer Publishing Company, 13 December 2009. Dostupné online. ISBN 0-8261-1094-0. S. 128–130. 
  • The American Psychiatric Publishing Textbook of Psychopharmacology. Redakce Schatzberg Alan F.. Fourth. vyd. [s.l.]: American Psychiatric Publishing, May 6, 2009. Dostupné online. ISBN 978-1-58562-309-9. S. 470. 
  • Hammersley D, Beeley L. Counselling: The BACP Counselling Reader. Redakce Palmer S, Dainow S, Milner P (eds.). [s.l.]: Sage, 1996. Dostupné online. ISBN 978-0803974777. Kapitola The effects of medication on counselling, s. 211–4. 
  • EBADI, Manuchair. Desk Reference for Clinical Pharmacology. 2nd. vyd. USA: CRC Press, 23 October 2007. Dostupné online. ISBN 978-1420047431. Kapitola Alphabetical presentation of drugs, s. 512. 
  • JACKSON, Stephen G.; JANSEN, Paul; MANGONI, Arduino. Prescribing for Elderly Patients. [s.l.]: Wiley, 22 May 2009. Dostupné online. ISBN 0-470-02428-3. S. 47–48. 
  • ROSENTHAL, Thomas C.; WILLIAMS, Mark; NAUGHTON, Bruce J. Office care geriatrics. Philadelphia: Lippincott Williams Wilkins, 2006. Dostupné online. ISBN 0-7817-6196-4. S. 260–262. 

doi.org

dx.doi.org

expert-reviews.com

medscape.com

emedicine.medscape.com

  • Robin Mantooth. Toxicity, benzodiazepine [online]. eMedicine, 28 January 2010 [cit. 2010-10-02]. Dostupné online. 

movementdisorders.org

  • TRENKWALDER, C.; HENING, WA.; MONTAGNA, P.; OERTEL, WH.; ALLEN, RP.; WALTERS, AS.; COSTA, J. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord. 2008, s. 2267–302. Dostupné v archivu pořízeném dne 29-12-2009. DOI 10.1002/mds.22254. PMID 18925578.  Archivovaná kopie. www.movementdisorders.org [online]. [cit. 2011-06-28]. Dostupné v archivu pořízeném z originálu. 

nelm.nhs.uk

nice.org.uk

  • Stokes T, Shaw EJ, Juarez-Garcia A, Camosso-Stefinovic J, Baker R. Clinical Guidelines and Evidence Review for the Epilepsies: diagnosis and management in adults and children in primary and secondary care. London: Royal College of General Practitioners, 2004. Dostupné online. S. 61, 64–65. 

nih.gov

ncbi.nlm.nih.gov

  • Olkkola KT, Ahonen J. Midazolam and other benzodiazepines. Handb Exp Pharmacol. 2008, roč. 182, čís. 182, s. 335–60. DOI 10.1007/978-3-540-74806-9_16. PMID 18175099. 
  • Saïas T, Gallarda T. [Paradoxical aggressive reactions to benzodiazepine use: a review]. Encephale. 2008, s. 330–6. DOI 10.1016/j.encep.2007.05.005. PMID 18922233. (French) 
  • Lader M. Effectiveness of benzodiazepines: do they work or not?. Expert Rev Neurother. 2008, roč. 8, čís. 8, s. 1189–91. Dostupné online. DOI 10.1586/14737175.8.8.1189. PMID 18671662. 
  • Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs. 2009, s. 19–34. DOI 10.2165/0023210-200923010-00002. PMID 19062773. 
  • Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry. 2005, roč. 18, čís. 3, s. 249–55. Dostupné online [PDF]. DOI 10.1097/01.yco.0000165594.60434.84. PMID 16639148. 
  • American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin no. 92: Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol. 2008, s. 1001–20. DOI 10.1097/AOG.0b013e31816fd910. PMID 18378767. 
  • Fraser AD. Use and abuse of the benzodiazepines. Ther Drug Monit. 1998, s. 481–9. DOI 10.1097/00007691-199810000-00007. PMID 9780123. 
  • Charlson F, Degenhardt L, McLaren J, Hall W, Lynskey M. A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf. 2009, s. 93–103. DOI 10.1002/pds.1694. PMID 19125401. 
  • White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999, s. 961–72. DOI 10.1046/j.1360-0443.1999.9479612.x. PMID 10707430. 
  • Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?. Eur Neuropsychopharmacol. 1999, s. S399–405. DOI 10.1016/S0924-977X(99)00051-6. PMID 10622686. 
  • Sternbach LH. The benzodiazepine story. J Med Chem. 1979, roč. 22, čís. 1, s. 1–7. DOI 10.1021/jm00187a001. PMID 34039. 
  • Miller NS, Gold MS. Benzodiazepines: reconsidered. Adv Alcohol Subst Abuse. 1990, roč. 8, čís. 3–4, s. 67–84. PMID 1971487. 
  • King MB. Is there still a role for benzodiazepines in general practice?. Br J Gen Pract. 1992, roč. 42, čís. 358, s. 202–5. Dostupné online [PDF]. PMID 1389432. [nedostupný zdroj]
  • JUFE, GS. [New hypnotics: perspectives from sleep physiology]. Vertex. Jul-Aug 2007, roč. 18, čís. 74, s. 294–9. PMID 18265473. 
  • Lemmer B. The sleep–wake cycle and sleeping pills. Physiol Behav. 2007, roč. 90, čís. 2–3, s. 285–93. DOI 10.1016/j.physbeh.2006.09.006. PMID 17049955. 
  • Perugi G, Frare F, Toni C. Diagnosis and treatment of agoraphobia with panic disorder. CNS Drugs. 2007, roč. 21, čís. 9, s. 741–64. DOI 10.2165/00023210-200721090-00004. PMID 17696574. 
  • Tesar GE. High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience. J Clin Psychiatry. 1990, roč. 51, čís. Suppl, s. 4–10; discussion 50–3. PMID 1970816. 
  • Faught E. Treatment of refractory primary generalized epilepsy. Rev Neurol Dis. 2004, roč. 1, čís. Suppl 1, s. S34–43. PMID 16400293. 
  • Allgulander C, Bandelow B, Hollander E. WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr. 2003, roč. 8, čís. Suppl 1, s. 53–61. PMID 14767398. 
  • Stevens JC, Pollack MH. Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents. Journal of Clinical Psychiatry. 2005, roč. 66, čís. Suppl 2, s. 21–27. PMID 15762816. 
  • Cloos JM, Ferreira V. Current use of benzodiazepines in anxiety disorders. Current Opinion in Psychiatry. 2009, roč. 22, čís. 1, s. 90–95. DOI 10.1097/YCO.0b013e32831a473d. PMID 19122540. 
  • Martin JL, Sainz-Pardo M, Furukawa TA, Martín-Sánchez E, Seoane T, Galán C. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J. Psychopharmacol. (Oxford). September 2007, roč. 21, čís. 7, s. 774–82. DOI 10.1177/0269881107077355. PMID 17881433. 
  • Canadian Psychiatric Association. Clinical practice guidelines. Management of anxiety disorders. Can J Psychiatry. July 2006, roč. 51, čís. 8 Suppl 2, s. 51S–55S. Dostupné v archivu pořízeném dne 2009-09-21. PMID 16933543.  Archivováno 21. 9. 2009 na Wayback Machine.
  • Ramakrishnan K, Scheid DC. Treatment options for insomnia. Am Fam Physician. August 2007, roč. 76, čís. 4, s. 517–26. Dostupné online. PMID 17853625.  Archivováno 20. 11. 2008 na Wayback Machine.
  • What's wrong with prescribing hypnotics?. Drug Ther Bull. 2004, roč. 42, čís. 12, s. 89–93. DOI 10.1136/dtb.2004.421289. PMID 15587763.  NeLM summary[nedostupný zdroj].
  • Shorvon SD. Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959-2009. Epilepsia. 2009, s. 93–130. Dostupné online. DOI 10.1111/j.1528-1167.2009.02042.x. PMID 19298435. 
  • Ashworth M, Gerada C. ABC of mental health. Addiction and dependence--II: Alcohol. BMJ. 1997, s. 358–60. PMID 9270461. 
  • Kraemer KL, Conigliaro J, Saitz R. Managing alcohol withdrawal in the elderly. Drugs Aging. 1999, s. 409–25. DOI 10.2165/00002512-199914060-00002. PMID 10408740. 
  • Prater CD, Miller KE, Zylstra RG. Outpatient detoxification of the addicted or alcoholic patient. American Family Physician. 1999, s. 1175–83. Dostupné online. PMID 10507746. 
  • Ebell MH. Benzodiazepines for alcohol withdrawal. American Family Physician. 2006, s. 1191. Dostupné online. PMID 16623205. 
  • Peppers MP. Benzodiazepines for alcohol withdrawal in the elderly and in patients with liver disease. Pharmacotherapy. 1996, s. 49–57. PMID 8700792. 
  • DEVLIN, JW.; ROBERTS, RJ. Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Crit Care Clin. 2009, s. 431–49, vii. DOI 10.1016/j.ccc.2009.03.003. PMID 19576523. 
  • BROSCHEIT, J.; KRANKE, P. [The preoperative medication: background and specific indications for the selection of the drugs]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2008, s. 134–43. DOI 10.1055/s-2008-1060547. PMID 18293248. 
  • BERTHOLD, C. Enteral sedation: safety, efficacy, and controversy. Compend Contin Educ Dent. 2007, s. 264–71; quiz 272, 282. PMID 17607891. 
  • Mañon-Espaillat R, Mandel S. Diagnostic algorithms for neuromuscular diseases. Clin Podiatr Med Surg. 1999, s. 67–79. PMID 9929772. 
  • KAMEN, L.; HENNEY, HR.; RUNYAN, JD. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. Curr Med Res Opin. 2008, s. 425–39. DOI 10.1185/030079908X261113. PMID 18167175. 
  • Zimbroff DL. Pharmacological control of acute agitation: focus on intramuscular preparations. CNS Drugs. 2008, s. 199–212. DOI 10.2165/00023210-200822030-00002. PMID 18278976. 
  • Curtin F, Schulz P. Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis. J Affect Disord. 2004, s. 201–8. DOI 10.1016/S0165-0327(02)00317-8. PMID 15013244. 
  • Gillies D, Beck A, McCloud A, Rathbone J, Gillies D. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. Redakce Gillies Donna. Cochrane Database Syst Rev. 2005, s. CD003079. DOI 10.1002/14651858.CD003079.pub2. PMID 16235313. 
  • SCHENCK, CH.; ARNULF, I.; MAHOWALD, MW. Sleep and sex: what can go wrong? A review of the literature on sleep related disorders and abnormal sexual behaviors and experiences. Sleep. 2007, s. 683–702. PMID 17580590. 
  • FERINI-STRAMBI, L.; ZUCCONI, M. REM sleep behavior disorder. Clin Neurophysiol. 2000, s. S136–40. PMID 10996567. 
  • SILBER, MH. Sleep disorders. Neurol Clin. 2001, s. 173–86. DOI 10.1016/S0733-8619(05)70011-6. PMID 11471763. 
  • Grupo Brasileiro de Estudos em Síndrome das Pernas Inquietas (GBE-SPI). Síndrome das pernas inquietas: diagnóstico e tratamento. Opinião de especialistas brasileiros. Arq. Neuro-Psiquiatr.. 2007, s. 721–7. ISSN 0004-282X. DOI 10.1590/S0004-282X2007000400035. PMID 17876423. (Portugese) 
  • TRENKWALDER, C.; HENING, WA.; MONTAGNA, P.; OERTEL, WH.; ALLEN, RP.; WALTERS, AS.; COSTA, J. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord. 2008, s. 2267–302. Dostupné v archivu pořízeném dne 29-12-2009. DOI 10.1002/mds.22254. PMID 18925578.  Archivovaná kopie. www.movementdisorders.org [online]. [cit. 2011-06-28]. Dostupné v archivu pořízeném z originálu. 
  • BANDELOW, B. The medical treatment of obsessive-compulsive disorder and anxiety. CNS Spectr. 2008, s. 37–46. PMID 18849910. 
  • ATTARD, A.; RANJITH, G.; TAYLOR, D. Delirium and its treatment. CNS Drugs. 2008, s. 631–44. DOI 10.2165/00023210-200822080-00002. PMID 18601302. 
  • Stone KL, Ensrud KE, Ancoli-Israel S. Sleep, insomnia and falls in elderly patients. Sleep Med.. 2008, s. S18–22. DOI 10.1016/S1389-9457(08)70012-1. PMID 18929314. 
  • Rapoport MJ, Lanctôt KL, Streiner DL. Benzodiazepine use and driving: a meta-analysis. J Clin Psychiatry. 2009, s. 663–73. DOI 10.4088/JCP.08m04325. PMID 19389334. 
  • Orriols L, Salmi LR, Philip P. The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf. 2009, s. 647–58. DOI 10.1002/pds.1763. PMID 19418468. 
  • RISS, J.; CLOYD, J.; GATES, J.; COLLINS, S. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008, s. 69–86. DOI 10.1111/j.1600-0404.2008.01004.x. PMID 18384456. 
  • Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs. 2004, s. 37–48. DOI 10.2165/00023210-200418010-00004. PMID 14731058. 
  • Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry. 2005, s. 9–13. Dostupné v archivu pořízeném dne 07-10-2011. PMID 15762814.  Archivovaná kopie. psychiatrist.com [online]. [cit. 2011-11-20]. Dostupné v archivu pořízeném z originálu. 
  • Nardi AE, Perna G. Clonazepam in the treatment of psychiatric disorders: an update. Int Clin Psychopharmacol. 2006, s. 131–42. DOI 10.1097/01.yic.0000194379.65460.a6. PMID 16528135. 
  • Longo LP, Johnson B. Addiction: Part I. Benzodiazepines--side effects, abuse risk and alternatives. American Family Physician. 2000, s. 2121–8. Dostupné v archivu pořízeném dne 2008-05-12. PMID 10779253. 
  • Otto MW, Bruce SE, Deckersbach T. Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need. J Clin Psychiatry. 2005, s. 34–8. Dostupné v archivu pořízeném dne 07-10-2011. PMID 15762818.  Archivovaná kopie. psychiatrist.com [online]. [cit. 2011-11-21]. Dostupné v archivu pořízeném z originálu. 
  • Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry. 2004, s. 7–12. Dostupné v archivu pořízeném dne 07-10-2011. PMID 15078112.  Archivovaná kopie. psychiatrist.com [online]. [cit. 2011-11-21]. Dostupné v archivu pořízeném z originálu. 
  • Ashton CH. Protracted withdrawal syndromes from benzodiazepines. J Subst Abuse Treat. 1991, s. 19–28. Dostupné online. DOI 10.1016/0740-5472(91)90023-4. PMID 1675688. 
  • Gaudreault P, Guay J, Thivierge RL, Verdy I. Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment. Drug Saf. 1991, s. 247–65. DOI 10.2165/00002018-199106040-00003. PMID 1888441. 
  • Klein-Schwartz W, Oderda GM. Poisoning in the elderly. Epidemiological, clinical and management considerations. Drugs Aging. 1991, s. 67–89. DOI 10.2165/00002512-199101010-00008. PMID 1794007. 
  • Buckley NA, Dawson AH, Whyte IM, O'Connell DL. Relative toxicity of benzodiazepines in overdose. BMJ. 1995, s. 219–221. DOI 10.1136/bmj.310.6974.219. PMID 7866122. 
  • Serfaty M, Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. British Journal of Psychiatry. 1994, s. 128–9. DOI 10.1192/bjp.163.3.386. PMID 8104653. 
  • Seger DL. Flumazenil—treatment or toxin. J Toxicol Clin Toxicol. 2004, s. 209–16. DOI 10.1081/CLT-120030946. PMID 15214628. 
  • Treatment of benzodiazepine overdose with flumazenil. The flumazenil in benzodiazepine intoxication multicenter study group. Clin Ther. 1992, s. 978–95. PMID 1286503. 
  • Spivey WH. Flumazenil and seizures: analysis of 43 cases. Clin Ther. 1992, s. 292–305. PMID 1611650. 
  • Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ. 1998, s. 839–43. Dostupné online. PMID 9748174. 
  • American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics. 1998, s. 1079–88. Dostupné online. PMID 9614425. 
  • Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate and the nursing infant. Psychiatr Serv. 2002, s. 39–49. Dostupné online [cit. 02-12-2011]. DOI 10.1176/appi.ps.53.1.39. PMID 11773648.  Archivovaná kopie. ps.psychiatryonline.org [online]. [cit. 2011-12-02]. Dostupné v archivu pořízeném z originálu. 
  • Tariq SH, Pulisetty S. Pharmacotherapy for insomnia. Clin Geriatr Med. 2008, s. 93–105, vii. DOI 10.1016/j.cger.2007.08.009. PMID 18035234. 
  • Bain KT. Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother. 2006, s. 168–92. DOI 10.1016/j.amjopharm.2006.06.006. PMID 16860264. 
  • Allain H, Bentué-Ferrer D, Polard E, Akwa Y, Patat A. Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging. 2005, s. 749–65. DOI 10.2165/00002512-200522090-00004. PMID 16156679. 
  • Bogunovic OJ, Greenfield SF. Practical geriatrics: Use of benzodiazepines among elderly patients. Psychiatr Serv. 2004, s. 233–5. Dostupné online. DOI 10.1176/appi.ps.55.3.233. PMID 15001721. 
  • Hulse GK, Lautenschlager NT, Tait RJ, Almeida OP. Dementia associated with alcohol and other drug use. Int Psychogeriatr. 2005, s. S109–27. DOI 10.1017/S1041610205001985. PMID 16240487. 
  • Verdoux H, Lagnaoui R, Begaud B. Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med. 2005, s. 307–15. DOI 10.1017/S0033291704003897. PMID 15841867. 
  • Snowden M, Sato K, Roy-Byrne P. Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature. J Am Geriatr Soc. 2003, s. 1305–17. DOI 10.1046/j.1532-5415.2003.51417.x. PMID 12919245. 
  • Wang PS, Brookhart MA, Setoguchi S, Patrick AR, Schneeweiss S. Psychotropic medication use for behavioral symptoms of dementia. Curr Neurol Neurosci Rep. 2006, s. 490–5. DOI 10.1007/s11910-006-0051-6. PMID 17074284. 

pubmedcentral.nih.gov

parliament.uk

publications.parliament.uk

  • Peart R. Memorandum by Dr Reg Peart [online]. Select Committee on Health, House of Commons, UK Parliament, 1999-06-01 [cit. 2009-05-27]. (Minutes of Evidence). Dostupné online. 

psychiatrist.com

  • Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry. 2005, s. 9–13. Dostupné v archivu pořízeném dne 07-10-2011. PMID 15762814.  Archivovaná kopie. psychiatrist.com [online]. [cit. 2011-11-20]. Dostupné v archivu pořízeném z originálu. 
  • Otto MW, Bruce SE, Deckersbach T. Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need. J Clin Psychiatry. 2005, s. 34–8. Dostupné v archivu pořízeném dne 07-10-2011. PMID 15762818.  Archivovaná kopie. psychiatrist.com [online]. [cit. 2011-11-21]. Dostupné v archivu pořízeném z originálu. 
  • Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry. 2004, s. 7–12. Dostupné v archivu pořízeném dne 07-10-2011. PMID 15078112.  Archivovaná kopie. psychiatrist.com [online]. [cit. 2011-11-21]. Dostupné v archivu pořízeném z originálu. 

psychiatryonline.com

  • Work Group on Panic Disorder. APA Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition [PDF]. January 2009 [cit. 2009-07-12]. Dostupné online. 

psychiatryonline.org

ps.psychiatryonline.org

psychservices.psychiatryonline.org

rcpsych.org

pb.rcpsych.org

web.archive.org

  • McIntosh A, Cohen A, Turnbull N et al.. Clinical guidelines and evidence review for panic disorder and generalised anxiety disorder [PDF]. National Collaborating Centre for Primary Care, 2004 [cit. 2009-06-16]. Dostupné v archivu pořízeném dne 2009-02-19. 
  • Barbui C, Cipriani A. Proposal for the inclusion in the WHO Model List of Essential Medicines of a selective serotonin-reuptake inhibitor for Generalised Anxiety Disorder [PDF]. WHO Collaborating Centre for Research and Training in Mental Health, 2009 [cit. 2009-06-23]. Dostupné v archivu pořízeném dne 2012-05-05. 
  • Canadian Psychiatric Association. Clinical practice guidelines. Management of anxiety disorders. Can J Psychiatry. July 2006, roč. 51, čís. 8 Suppl 2, s. 51S–55S. Dostupné v archivu pořízeném dne 2009-09-21. PMID 16933543.  Archivováno 21. 9. 2009 na Wayback Machine.
  • Technology Appraisal Guidance 77. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia [PDF]. National Institute for Clinical Excellence, April 2004 [cit. 2009-07-26]. Dostupné v archivu pořízeném dne 2008-12-03. 
  • Ramakrishnan K, Scheid DC. Treatment options for insomnia. Am Fam Physician. August 2007, roč. 76, čís. 4, s. 517–26. Dostupné online. PMID 17853625.  Archivováno 20. 11. 2008 na Wayback Machine.
  • Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M. Manifestations and Management of Chronic Insomnia in Adults. Agency for Healthcare Research and Quality. Evidence Report/Technology Assessment Number 125 [PDF]. June 2005 [cit. 2010-12-22]. Dostupné v archivu pořízeném dne 2011-05-23. 
  • Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy in adults [online]. [cit. 2009-06-05]. S. 17–9. Dostupné v archivu pořízeném dne 2009-01-26. 
  • Stokes T, Shaw EJ, Juarez-Garcia A, Camosso-Stefinovic J, Baker R. Clinical Guidelines and Evidence Review for the Epilepsies: diagnosis and management in adults and children in primary and secondary care (Appendix B) [online]. Royal College of General Practitioners [cit. 2009-06-02]. S. 432. Dostupné v archivu pořízeném dne 2011-11-27. 
  • TRENKWALDER, C.; HENING, WA.; MONTAGNA, P.; OERTEL, WH.; ALLEN, RP.; WALTERS, AS.; COSTA, J. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord. 2008, s. 2267–302. Dostupné v archivu pořízeném dne 29-12-2009. DOI 10.1002/mds.22254. PMID 18925578.  Archivovaná kopie. www.movementdisorders.org [online]. [cit. 2011-06-28]. Dostupné v archivu pořízeném z originálu. 
  • Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry. 2005, s. 9–13. Dostupné v archivu pořízeném dne 07-10-2011. PMID 15762814.  Archivovaná kopie. psychiatrist.com [online]. [cit. 2011-11-20]. Dostupné v archivu pořízeném z originálu. 
  • Longo LP, Johnson B. Addiction: Part I. Benzodiazepines--side effects, abuse risk and alternatives. American Family Physician. 2000, s. 2121–8. Dostupné v archivu pořízeném dne 2008-05-12. PMID 10779253. 
  • Otto MW, Bruce SE, Deckersbach T. Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need. J Clin Psychiatry. 2005, s. 34–8. Dostupné v archivu pořízeném dne 07-10-2011. PMID 15762818.  Archivovaná kopie. psychiatrist.com [online]. [cit. 2011-11-21]. Dostupné v archivu pořízeném z originálu. 
  • Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry. 2004, s. 7–12. Dostupné v archivu pořízeném dne 07-10-2011. PMID 15078112.  Archivovaná kopie. psychiatrist.com [online]. [cit. 2011-11-21]. Dostupné v archivu pořízeném z originálu. 
  • Lal R, Gupta S, Rao R, Kattimani S. Substance Use Disorder. [s.l.]: World Health Organization (WHO), 2007. Dostupné online. Kapitola Emergency management of substance overdose and withdrawal, s. 82.  Archivovaná kopie. www.whoindia.org [online]. [cit. 2011-11-26]. Dostupné v archivu pořízeném z originálu. 
  • Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate and the nursing infant. Psychiatr Serv. 2002, s. 39–49. Dostupné online [cit. 02-12-2011]. DOI 10.1176/appi.ps.53.1.39. PMID 11773648.  Archivovaná kopie. ps.psychiatryonline.org [online]. [cit. 2011-12-02]. Dostupné v archivu pořízeném z originálu. 

webcitation.org

  • Clinical Guideline 22 (amended). Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care [PDF]. National Institute for Health and Clinical Excellence, 2007 [cit. 2009-08-08]. S. 23–25. Dostupné v archivu pořízeném dne 2012-06-06. 
  • Committee on Safety of Medicines. Benzodiazepines, dependence and withdrawal symptoms [PDF]. Medicines and Healthcare products Regulatory Agency [cit. 2009-05-28]. Dostupné v archivu pořízeném dne 2012-06-06. 

whoindia.org

wiley.com

onlinelibrary.wiley.com

worldcat.org

  • Grupo Brasileiro de Estudos em Síndrome das Pernas Inquietas (GBE-SPI). Síndrome das pernas inquietas: diagnóstico e tratamento. Opinião de especialistas brasileiros. Arq. Neuro-Psiquiatr.. 2007, s. 721–7. ISSN 0004-282X. DOI 10.1590/S0004-282X2007000400035. PMID 17876423. (Portugese)